HANSOH PHARMA PRESENTS POSITIVE PHASE II CLINICAL STUDY OF HS-10374, IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AT CDA 2024
SHANGHAI, November 29, 2024 — Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK) today announced that the positive phase II clinical stud...
2024.11.29